For applicable clinical trials regulated by the U.S. Food and Drug Administration (FDA) that are initiated on or after March 7, 2012, sponsors, investigators and institutional review boards will have to assure compliance with an additional informed consent requirement.

Click on the PDF link above to view the full alert.

Source: Health Care Client Alert
Leave Drinker Biddle to Learn More